Cargando…

Comparing Outcomes of Oligometastases Treated with Hypofractionated Image-Guided Radiotherapy (HIGRT) with a Simultaneous Integrated Boost (SIB) Technique versus Metastasis Alone: A Multi-Institutional Analysis

SIMPLE SUMMARY: Hypofractionated image-guided radiotherapy (HIGRT) is a common method in which high doses of radiation are delivered to treat oligometastatic disease. We have previously reported on the clinical outcomes of treating oligometastases with radiation using an elective simultaneous integr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shenker, Rachel F., Price, Jeremy G., Jacobs, Corbin D., Palta, Manisha, Czito, Brian G., Mowery, Yvonne M., Kirkpatrick, John P., Boyer, Matthew J., Oyekunle, Taofik, Niedzwiecki, Donna, Song, Haijun, Salama, Joseph K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139819/ https://www.ncbi.nlm.nih.gov/pubmed/35626008 http://dx.doi.org/10.3390/cancers14102403

Ejemplares similares

Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis
por: Jacobs, Corbin D., et al.
Publicado: (2019)

Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer
por: Natesan, Divya, et al.
Publicado: (2021)

Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases
por: Billiet, Charlotte, et al.
Publicado: (2020)

Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers
por: Osman, Sarah O. S., et al.
Publicado: (2022)

RADI-09. Clinical factors associated with death after radiotherapy for brain metastases
por: Natesan, Divya, et al.
Publicado: (2021)

Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study
por: Jorgo, Kliton, et al.
Publicado: (2019)

Oligometastases in prostate cancer: Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT
por: Baumann, René, et al.
Publicado: (2017)

Oligometastases/Oligo-Recurrence of Lung Cancer
por: Niibe, Yuzuru, et al.
Publicado: (2013)

Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques
por: Aly, Moamen M.O.M., et al.
Publicado: (2015)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
por: Aujla, Khush S., et al.
Publicado: (2019)

Clinical Factors Associated With 30-Day Mortality Among Patients Undergoing Radiation Therapy for Brain Metastases
por: Natesan, Divya, et al.
Publicado: (2023)

Deep Learning–Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost
por: Wang, Wentao, et al.
Publicado: (2021)

Establishing ADC-Based Histogram and Texture Features for Early Treatment-Induced Changes in Head and Neck Squamous Cell Carcinoma
por: Rodrigues, Anna, et al.
Publicado: (2021)

Moderately Hypofractionated Radiotherapy Alone for Stage I-IIB Non-small Cell Lung Cancer
por: Hughes, Ryan T, et al.
Publicado: (2019)

A current perspective on stereotactic body radiation therapy for pancreatic cancer
por: Hong, Julian C, et al.
Publicado: (2016)

A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
por: Li, Chen, et al.
Publicado: (2019)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Multi-Institutional Analysis of Synchronous Prostate and Rectosigmoid Cancers
por: Jacobs, Corbin D., et al.
Publicado: (2020)

IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients
por: Studer, G, et al.
Publicado: (2006)

Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
por: Li, Chen, et al.
Publicado: (2019)

Effective Pain Control With Very Low Dose Palliative Radiation Therapy for Patients With Multiple Myeloma With Uncomplicated Osseous Lesions
por: Price, Jeremy G., et al.
Publicado: (2021)

Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement
por: Acklin-Wehnert, Scarlett, et al.
Publicado: (2023)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer
por: Ahmad Khalil, Dalia, et al.
Publicado: (2022)

Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: A feasible technique for developing countries
por: Tiwari, Vivek, et al.
Publicado: (2015)

Oligometastases in prostate cancer: Ablative treatment
por: Palacios-Eito, Amalia, et al.
Publicado: (2019)

Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer
por: Feng, Christine H., et al.
Publicado: (2016)

Survey of Healthcare Providers Utilization and Perception of Telehealth On-Treatment Visits During COVID-19 Pandemic
por: Shenker, R.F., et al.
Publicado: (2021)

Sib1, Sib2, and Sib3 proteins are required for ferrichrome-mediated cross-feeding interaction between Schizosaccharomyces pombe and Saccharomyces cerevisiae
por: Brault, Ariane, et al.
Publicado: (2022)

A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases
por: Rodrigues, George, et al.
Publicado: (2019)

Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy
por: Rotondi, Margherita, et al.
Publicado: (2023)

Mysterious SiB(3): Identifying the Relation between α- and β-SiB(3)
por: Eklöf, Daniel, et al.
Publicado: (2019)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
por: Onderdonk, Benjamin E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_57t1apd4bsdctu9p7s9a4igtks